Unknown

Dataset Information

0

Antibody Titers After a Third and Fourth SARS-CoV-2 BNT162b2 Vaccine Dose in Older Adults.

ABSTRACT:

SUBMITTER: Eliakim-Raz N 

PROVIDER: S-EPMC9305380 | biostudies-literature | 2022 Jul

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Antibody Titers After a Third and Fourth SARS-CoV-2 BNT162b2 Vaccine Dose in Older Adults.

Eliakim-Raz Noa N   Stemmer Amos A   Ghantous Nassem N   Ness Asaf A   Awwad Muhammad M   Leibovici-Weisman Yaara Y   Stemmer Salomon M SM  

JAMA network open 20220701 7

Similar Datasets

Unknown Effect of the third dose of BNT162b2 vaccine on quantitative SARS-CoV-2 spike 1-2 IgG antibody titers in healthcare personnel.
| S-EPMC8890651 | biostudies-literature
Unknown The effect of a third-dose BNT162b2 vaccine on anti-SARS-CoV-2 antibody levels in immunosuppressed patients.
| S-EPMC8853982 | biostudies-literature
Unknown Sex-associated differences between BMI and SARS-CoV-2 antibody titers following the BNT162b2 vaccine.
| S-EPMC9088326 | biostudies-literature
Unknown SARS-CoV-2 specific antibody responses in healthcare workers after a third booster dose of CoronaVac or BNT162b2 vaccine.
| S-EPMC9088656 | biostudies-literature
Unknown Antibody titres before and after a third dose of the SARS-CoV-2 BNT162b2 vaccine in patients with cancer.
| S-EPMC8714294 | biostudies-literature
Unknown Association between γ-Glutamyl Transpeptidase and SARS-CoV-2 Spike Antibody Titers among BNT162b2 Vaccine Recipients.
| S-EPMC9785427 | biostudies-literature
Unknown Antibody and T-cell response to a third dose of SARS-CoV-2 mRNA BNT162b2 vaccine in kidney transplant recipients.
| S-EPMC8489274 | biostudies-literature
Unknown SARS-CoV-2 Antibody Response After a Third Dose of the BNT162b2 Vaccine in Patients Receiving Maintenance Hemodialysis or Peritoneal Dialysis.
| S-EPMC8425695 | biostudies-literature
Unknown Effect of the third dose of BNT162b2 COVID-19 mRNA vaccine on anti-SARS-CoV-2 antibody levels in healthcare workers.
| S-EPMC9684125 | biostudies-literature
Unknown Low neutralizing antibody responses against SARS-CoV-2 in older patients with myeloma after the first BNT162b2 vaccine dose.
| S-EPMC8061093 | biostudies-literature